TY - JOUR
T1 - Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor
AU - De Leon, Emma Diaz
AU - Carcangiu, Maria Luisa
AU - Prieto, Victor G.
AU - McCue, Peter A.
AU - Burchette, James L.
AU - To, Gia
AU - Norris, Brent A.
AU - Kovatich, Albert J.
AU - Sanchez, Ramon L.
AU - Krigman, Hannah R.
AU - Gatalica, Zoran
PY - 2000
Y1 - 2000
N2 - Extramammary Paget disease (EPD) is an uncommon cutaneous malignant neoplasm that arises in areas rich in apocrine glands (perineum, vulva, and axilla). Apocrine gland origin or apocrine differentiation of cells of EPD has been suggested. Estrogen, progesterone, and androgen hormone receptors have been reported to exhibit a characteristic pattern of expression in mammary apocrine type carcinomas; however, their expression in EPD has not been elucidated fully. By using immunohistochemical methods, we studied the expression of steroid receptors in EPD on formalin-fixed paraffin-embedded tissue samples from 28 patients with EPD without associated visceral malignant neoplasms or adnexal carcinoma. Androgen receptor (AR) was identified in 15 of 28 cases. The proportion of AR-positive cells varied from 1% to more than 75%; 8 cases expressed AR in more than 10% of cells. Strong AR expression also was seen fit the invasive carcinoma arising from 1 case of EPD. All cases lacked immunohistochemically detectable estrogen and progesterone receptors. The immunophenotype characteristic of apocrine carcinomas (AR-positive, estrogen receptor-negative, progesterone receptor- negative) was seen in a substantial proportion of EPD cases. Results suggest that AR expression is a factor in pathogenesis of EPD. This may be important for the therapy of recurrent or invasive disease.
AB - Extramammary Paget disease (EPD) is an uncommon cutaneous malignant neoplasm that arises in areas rich in apocrine glands (perineum, vulva, and axilla). Apocrine gland origin or apocrine differentiation of cells of EPD has been suggested. Estrogen, progesterone, and androgen hormone receptors have been reported to exhibit a characteristic pattern of expression in mammary apocrine type carcinomas; however, their expression in EPD has not been elucidated fully. By using immunohistochemical methods, we studied the expression of steroid receptors in EPD on formalin-fixed paraffin-embedded tissue samples from 28 patients with EPD without associated visceral malignant neoplasms or adnexal carcinoma. Androgen receptor (AR) was identified in 15 of 28 cases. The proportion of AR-positive cells varied from 1% to more than 75%; 8 cases expressed AR in more than 10% of cells. Strong AR expression also was seen fit the invasive carcinoma arising from 1 case of EPD. All cases lacked immunohistochemically detectable estrogen and progesterone receptors. The immunophenotype characteristic of apocrine carcinomas (AR-positive, estrogen receptor-negative, progesterone receptor- negative) was seen in a substantial proportion of EPD cases. Results suggest that AR expression is a factor in pathogenesis of EPD. This may be important for the therapy of recurrent or invasive disease.
KW - Extramammary Paget disease
KW - Immunohistochemistry
KW - Skin neoplasms
KW - Steroid hormone receptors
UR - http://www.scopus.com/inward/record.url?scp=0034049669&partnerID=8YFLogxK
U2 - 10.1309/p756-xxcb-tv71-u4xv
DO - 10.1309/p756-xxcb-tv71-u4xv
M3 - Article
C2 - 10761460
AN - SCOPUS:0034049669
SN - 0002-9173
VL - 113
SP - 572
EP - 575
JO - American Journal of Clinical Pathology
JF - American Journal of Clinical Pathology
IS - 4
ER -